世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バイオ医薬品の分析試験サービスの世界市場 2023-2027


Global Biopharmaceutical Analytical Testing Services Market 2023-2027

バイオ医薬品の分析試験サービスの世界市場 2023-2027 Technavioは、バイオ医薬品の分析試験サービス市場をモニターしており、2022年から2027年の間に3億4957万ドル、予測期間中のCAGRは12.61%で加速して成長す... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2023年1月18日 US$2,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
171 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

バイオ医薬品の分析試験サービスの世界市場 2023-2027
Technavioは、バイオ医薬品の分析試験サービス市場をモニターしており、2022年から2027年の間に3億4957万ドル、予測期間中のCAGRは12.61%で加速して成長すると予測しています。当レポートでは、バイオ医薬品の分析試験サービス市場について、全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新トレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、mAbの需要の増加、特許切れの薬剤の増加、慢性疾患の増加によって牽引されています。
Technavioのバイオ医薬品分析試験サービス市場は以下のように区分されます:
サービス別
- バイオアナリティカル
- メソッド開発およびバリデーション
- 安定性試験
- その他
エンドユーザー別
- ファーマ
- バイオテクノロジー企業
- CRO
地理的景観別
- 北アメリカ
- APAC
- ヨーロッパ
- 南米
- 中近東・アフリカ
本調査では、今後数年間のバイオ医薬品分析試験サービス市場の成長を促進する主な理由の一つとして、研究開発への投資の増加を挙げています。また、ワクチン製造の増加や分析試験サービスのアウトソーシングの増加は、市場の大きな需要につながるでしょう。
Technavioは、主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法によって、市場の詳細な画像を提示します。バイオ医薬品の分析試験サービス市場に関する当レポートは、以下の分野をカバーしています:
- バイオ医薬品の分析試験サービス市場のサイジング
- バイオ医薬品の分析試験サービス市場予測
- バイオ医薬品の分析試験サービス市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上させることを目的としており、これに沿って本レポートでは、Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc.を含むバイオ医薬品分析試験サービス市場の主要ベンダー数社の詳細分析を提供しています、Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp.of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp, SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc.また、バイオ医薬品分析検査サービス市場分析レポートには、市場成長に影響を与える今後の動向と課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/biopharmaceutical-analytical-testing-services-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biopharmaceutical analytical testing services market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
o 4.2 Service Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Service
o 6.1 Market segments
o Exhibit 30: Chart on Service - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
o 6.2 Comparison by Service
o Exhibit 32: Chart on Comparison by Service
o Exhibit 33: Data Table on Comparison by Service
o 6.3 Bioanalytical - Market size and forecast 2022-2027
o Exhibit 34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
o 6.4 Method development and validation - Market size and forecast 2022-2027
o Exhibit 38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
o 6.5 Stability testing - Market size and forecast 2022-2027
o Exhibit 42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Service
o Exhibit 50: Market opportunity by Service ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 53: Chart on Comparison by End-user
o Exhibit 54: Data Table on Comparison by End-user
o 7.3 Pharma and biotech companies - Market size and forecast 2022-2027
o Exhibit 55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
o 7.4 CROs - Market size and forecast 2022-2027
o Exhibit 59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on CROs - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 63: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 APAC - Market size and forecast 2022-2027
o Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 South America - Market size and forecast 2022-2027
o Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%)
o 9.7 Middle East and Africa - Market size and forecast 2022-2027
o Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o 9.8 US - Market size and forecast 2022-2027
o Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Germany - Market size and forecast 2022-2027
o Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Almac Group Ltd.
o Exhibit 116: Almac Group Ltd. - Overview
o Exhibit 117: Almac Group Ltd. - Product / Service
o Exhibit 118: Almac Group Ltd. - Key offerings
o 12.4 Boston Analytical
o Exhibit 119: Boston Analytical - Overview
o Exhibit 120: Boston Analytical - Product / Service
o Exhibit 121: Boston Analytical - Key news
o Exhibit 122: Boston Analytical - Key offerings
o 12.5 Catalent Inc.
o Exhibit 123: Catalent Inc. - Overview
o Exhibit 124: Catalent Inc. - Business segments
o Exhibit 125: Catalent Inc. - Key news
o Exhibit 126: Catalent Inc. - Key offerings
o Exhibit 127: Catalent Inc. - Segment focus
o 12.6 Charles River Laboratories International Inc.
o Exhibit 128: Charles River Laboratories International Inc. - Overview
o Exhibit 129: Charles River Laboratories International Inc. - Business segments
o Exhibit 130: Charles River Laboratories International Inc. - Key news
o Exhibit 131: Charles River Laboratories International Inc. - Key offerings
o Exhibit 132: Charles River Laboratories International Inc. - Segment focus
o 12.7 Coriolis Pharma Research GmbH
o Exhibit 133: Coriolis Pharma Research GmbH - Overview
o Exhibit 134: Coriolis Pharma Research GmbH - Product / Service
o Exhibit 135: Coriolis Pharma Research GmbH - Key offerings
o 12.8 Element Materials Technology Group Ltd.
o Exhibit 136: Element Materials Technology Group Ltd. - Overview
o Exhibit 137: Element Materials Technology Group Ltd. - Product / Service
o Exhibit 138: Element Materials Technology Group Ltd. - Key offerings
o 12.9 Eurofins Scientific SE
o Exhibit 139: Eurofins Scientific SE - Overview
o Exhibit 140: Eurofins Scientific SE - Business segments
o Exhibit 141: Eurofins Scientific SE - Key news
o Exhibit 142: Eurofins Scientific SE - Key offerings
o Exhibit 143: Eurofins Scientific SE - Segment focus
o 12.10 ICON plc
o Exhibit 144: ICON plc - Overview
o Exhibit 145: ICON plc - Product / Service
o Exhibit 146: ICON plc - Key offerings
o 12.11 Intertek Group Plc
o Exhibit 147: Intertek Group Plc - Overview
o Exhibit 148: Intertek Group Plc - Business segments
o Exhibit 149: Intertek Group Plc - Key news
o Exhibit 150: Intertek Group Plc - Key offerings
o Exhibit 151: Intertek Group Plc - Segment focus
o 12.12 Merck KGaA
o Exhibit 152: Merck KGaA - Overview
o Exhibit 153: Merck KGaA - Business segments
o Exhibit 154: Merck KGaA - Key news
o Exhibit 155: Merck KGaA - Key offerings
o Exhibit 156: Merck KGaA - Segment focus
o 12.13 Pace Analytical Services LLC
o Exhibit 157: Pace Analytical Services LLC - Overview
o Exhibit 158: Pace Analytical Services LLC - Product / Service
o Exhibit 159: Pace Analytical Services LLC - Key offerings
o 12.14 SGS SA
o Exhibit 160: SGS SA - Overview
o Exhibit 161: SGS SA - Business segments
o Exhibit 162: SGS SA - Key offerings
o Exhibit 163: SGS SA - Segment focus
o 12.15 Solvias AG
o Exhibit 164: Solvias AG - Overview
o Exhibit 165: Solvias AG - Product / Service
o Exhibit 166: Solvias AG - Key news
o Exhibit 167: Solvias AG - Key offerings
o 12.16 STERIS Plc
o Exhibit 168: STERIS Plc - Overview
o Exhibit 169: STERIS Plc - Business segments
o Exhibit 170: STERIS Plc - Key news
o Exhibit 171: STERIS Plc - Key offerings
o Exhibit 172: STERIS Plc - Segment focus
o 12.17 West Pharmaceutical Services Inc.
o Exhibit 173: West Pharmaceutical Services Inc. - Overview
o Exhibit 174: West Pharmaceutical Services Inc. - Business segments
o Exhibit 175: West Pharmaceutical Services Inc. - Key news
o Exhibit 176: West Pharmaceutical Services Inc. - Key offerings
o Exhibit 177: West Pharmaceutical Services Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations
o Stability and Storage
o growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
o product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Service
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Service - Market share 2022-2027 (%)
Exhibits31: Data Table on Service - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Service
Exhibits33: Data Table on Comparison by Service
Exhibits34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Service ($ million)
Exhibits51: Chart on End-user - Market share 2022-2027 (%)
Exhibits52: Data Table on End-user - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by End-user
Exhibits54: Data Table on Comparison by End-user
Exhibits55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by End-user ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on South America - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Almac Group Ltd. - Overview
Exhibits117: Almac Group Ltd. - Product / Service
Exhibits118: Almac Group Ltd. - Key offerings
Exhibits119: Boston Analytical - Overview
Exhibits120: Boston Analytical - Product / Service
Exhibits121: Boston Analytical - Key news
Exhibits122: Boston Analytical - Key offerings
Exhibits123: Catalent Inc. - Overview
Exhibits124: Catalent Inc. - Business segments
Exhibits125: Catalent Inc. - Key news
Exhibits126: Catalent Inc. - Key offerings
Exhibits127: Catalent Inc. - Segment focus
Exhibits128: Charles River Laboratories International Inc. - Overview
Exhibits129: Charles River Laboratories International Inc. - Business segments
Exhibits130: Charles River Laboratories International Inc. - Key news
Exhibits131: Charles River Laboratories International Inc. - Key offerings
Exhibits132: Charles River Laboratories International Inc. - Segment focus
Exhibits133: Coriolis Pharma Research GmbH - Overview
Exhibits134: Coriolis Pharma Research GmbH - Product / Service
Exhibits135: Coriolis Pharma Research GmbH - Key offerings
Exhibits136: Element Materials Technology Group Ltd. - Overview
Exhibits137: Element Materials Technology Group Ltd. - Product / Service
Exhibits138: Element Materials Technology Group Ltd. - Key offerings
Exhibits139: Eurofins Scientific SE - Overview
Exhibits140: Eurofins Scientific SE - Business segments
Exhibits141: Eurofins Scientific SE - Key news
Exhibits142: Eurofins Scientific SE - Key offerings
Exhibits143: Eurofins Scientific SE - Segment focus
Exhibits144: ICON plc - Overview
Exhibits145: ICON plc - Product / Service
Exhibits146: ICON plc - Key offerings
Exhibits147: Intertek Group Plc - Overview
Exhibits148: Intertek Group Plc - Business segments
Exhibits149: Intertek Group Plc - Key news
Exhibits150: Intertek Group Plc - Key offerings
Exhibits151: Intertek Group Plc - Segment focus
Exhibits152: Merck KGaA - Overview
Exhibits153: Merck KGaA - Business segments
Exhibits154: Merck KGaA - Key news
Exhibits155: Merck KGaA - Key offerings
Exhibits156: Merck KGaA - Segment focus
Exhibits157: Pace Analytical Services LLC - Overview
Exhibits158: Pace Analytical Services LLC - Product / Service
Exhibits159: Pace Analytical Services LLC - Key offerings
Exhibits160: SGS SA - Overview
Exhibits161: SGS SA - Business segments
Exhibits162: SGS SA - Key offerings
Exhibits163: SGS SA - Segment focus
Exhibits164: Solvias AG - Overview
Exhibits165: Solvias AG - Product / Service
Exhibits166: Solvias AG - Key news
Exhibits167: Solvias AG - Key offerings
Exhibits168: STERIS Plc - Overview
Exhibits169: STERIS Plc - Business segments
Exhibits170: STERIS Plc - Key news
Exhibits171: STERIS Plc - Key offerings
Exhibits172: STERIS Plc - Segment focus
Exhibits173: West Pharmaceutical Services Inc. - Overview
Exhibits174: West Pharmaceutical Services Inc. - Business segments
Exhibits175: West Pharmaceutical Services Inc. - Key news
Exhibits176: West Pharmaceutical Services Inc. - Key offerings
Exhibits177: West Pharmaceutical Services Inc. - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Biopharmaceutical Analytical Testing Services Market 2023-2027
Technavio has been monitoring the biopharmaceutical analytical testing services market and is forecast to grow by $3449.57 mn during 2022-2027, accelerating at a CAGR of 12.61% during the forecast period. Our report on the biopharmaceutical analytical testing services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increase in demand for mAbs, an increase in the number of patent-expired drugs, and an increase in chronic diseases.
Technavio's biopharmaceutical analytical testing services market is segmented as below:
By Service
• Bioanalytical
• Method development and validation
• Stability testing
• Others
By End-user
• Pharma
• biotech companies
• CROs
By Geographical Landscape
• North America
• APAC
• Europe
• South America
• Middle East and Africa
This study identifies the rise in investment in r and d as one of the prime reasons driving the biopharmaceutical analytical testing services market growth during the next few years. Also, the rise in the production of vaccines and increasing outsourcing of analytical testing services will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biopharmaceutical analytical testing services market covers the following areas:
• Biopharmaceutical analytical testing services market sizing
• Biopharmaceutical analytical testing services market forecast
• Biopharmaceutical analytical testing services market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biopharmaceutical analytical testing services market vendors that include Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc. Also, the biopharmaceutical analytical testing services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/biopharmaceutical-analytical-testing-services-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biopharmaceutical analytical testing services market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
o 4.2 Service Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Service
o 6.1 Market segments
o Exhibit 30: Chart on Service - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
o 6.2 Comparison by Service
o Exhibit 32: Chart on Comparison by Service
o Exhibit 33: Data Table on Comparison by Service
o 6.3 Bioanalytical - Market size and forecast 2022-2027
o Exhibit 34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
o 6.4 Method development and validation - Market size and forecast 2022-2027
o Exhibit 38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
o 6.5 Stability testing - Market size and forecast 2022-2027
o Exhibit 42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Service
o Exhibit 50: Market opportunity by Service ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 53: Chart on Comparison by End-user
o Exhibit 54: Data Table on Comparison by End-user
o 7.3 Pharma and biotech companies - Market size and forecast 2022-2027
o Exhibit 55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
o 7.4 CROs - Market size and forecast 2022-2027
o Exhibit 59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on CROs - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 63: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 APAC - Market size and forecast 2022-2027
o Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 South America - Market size and forecast 2022-2027
o Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%)
o 9.7 Middle East and Africa - Market size and forecast 2022-2027
o Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o 9.8 US - Market size and forecast 2022-2027
o Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Germany - Market size and forecast 2022-2027
o Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Almac Group Ltd.
o Exhibit 116: Almac Group Ltd. - Overview
o Exhibit 117: Almac Group Ltd. - Product / Service
o Exhibit 118: Almac Group Ltd. - Key offerings
o 12.4 Boston Analytical
o Exhibit 119: Boston Analytical - Overview
o Exhibit 120: Boston Analytical - Product / Service
o Exhibit 121: Boston Analytical - Key news
o Exhibit 122: Boston Analytical - Key offerings
o 12.5 Catalent Inc.
o Exhibit 123: Catalent Inc. - Overview
o Exhibit 124: Catalent Inc. - Business segments
o Exhibit 125: Catalent Inc. - Key news
o Exhibit 126: Catalent Inc. - Key offerings
o Exhibit 127: Catalent Inc. - Segment focus
o 12.6 Charles River Laboratories International Inc.
o Exhibit 128: Charles River Laboratories International Inc. - Overview
o Exhibit 129: Charles River Laboratories International Inc. - Business segments
o Exhibit 130: Charles River Laboratories International Inc. - Key news
o Exhibit 131: Charles River Laboratories International Inc. - Key offerings
o Exhibit 132: Charles River Laboratories International Inc. - Segment focus
o 12.7 Coriolis Pharma Research GmbH
o Exhibit 133: Coriolis Pharma Research GmbH - Overview
o Exhibit 134: Coriolis Pharma Research GmbH - Product / Service
o Exhibit 135: Coriolis Pharma Research GmbH - Key offerings
o 12.8 Element Materials Technology Group Ltd.
o Exhibit 136: Element Materials Technology Group Ltd. - Overview
o Exhibit 137: Element Materials Technology Group Ltd. - Product / Service
o Exhibit 138: Element Materials Technology Group Ltd. - Key offerings
o 12.9 Eurofins Scientific SE
o Exhibit 139: Eurofins Scientific SE - Overview
o Exhibit 140: Eurofins Scientific SE - Business segments
o Exhibit 141: Eurofins Scientific SE - Key news
o Exhibit 142: Eurofins Scientific SE - Key offerings
o Exhibit 143: Eurofins Scientific SE - Segment focus
o 12.10 ICON plc
o Exhibit 144: ICON plc - Overview
o Exhibit 145: ICON plc - Product / Service
o Exhibit 146: ICON plc - Key offerings
o 12.11 Intertek Group Plc
o Exhibit 147: Intertek Group Plc - Overview
o Exhibit 148: Intertek Group Plc - Business segments
o Exhibit 149: Intertek Group Plc - Key news
o Exhibit 150: Intertek Group Plc - Key offerings
o Exhibit 151: Intertek Group Plc - Segment focus
o 12.12 Merck KGaA
o Exhibit 152: Merck KGaA - Overview
o Exhibit 153: Merck KGaA - Business segments
o Exhibit 154: Merck KGaA - Key news
o Exhibit 155: Merck KGaA - Key offerings
o Exhibit 156: Merck KGaA - Segment focus
o 12.13 Pace Analytical Services LLC
o Exhibit 157: Pace Analytical Services LLC - Overview
o Exhibit 158: Pace Analytical Services LLC - Product / Service
o Exhibit 159: Pace Analytical Services LLC - Key offerings
o 12.14 SGS SA
o Exhibit 160: SGS SA - Overview
o Exhibit 161: SGS SA - Business segments
o Exhibit 162: SGS SA - Key offerings
o Exhibit 163: SGS SA - Segment focus
o 12.15 Solvias AG
o Exhibit 164: Solvias AG - Overview
o Exhibit 165: Solvias AG - Product / Service
o Exhibit 166: Solvias AG - Key news
o Exhibit 167: Solvias AG - Key offerings
o 12.16 STERIS Plc
o Exhibit 168: STERIS Plc - Overview
o Exhibit 169: STERIS Plc - Business segments
o Exhibit 170: STERIS Plc - Key news
o Exhibit 171: STERIS Plc - Key offerings
o Exhibit 172: STERIS Plc - Segment focus
o 12.17 West Pharmaceutical Services Inc.
o Exhibit 173: West Pharmaceutical Services Inc. - Overview
o Exhibit 174: West Pharmaceutical Services Inc. - Business segments
o Exhibit 175: West Pharmaceutical Services Inc. - Key news
o Exhibit 176: West Pharmaceutical Services Inc. - Key offerings
o Exhibit 177: West Pharmaceutical Services Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations
o Stability and Storage
o growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
o product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Service
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Service Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Service - Market share 2022-2027 (%)
Exhibits31: Data Table on Service - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Service
Exhibits33: Data Table on Comparison by Service
Exhibits34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Service ($ million)
Exhibits51: Chart on End-user - Market share 2022-2027 (%)
Exhibits52: Data Table on End-user - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by End-user
Exhibits54: Data Table on Comparison by End-user
Exhibits55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by End-user ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on South America - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Almac Group Ltd. - Overview
Exhibits117: Almac Group Ltd. - Product / Service
Exhibits118: Almac Group Ltd. - Key offerings
Exhibits119: Boston Analytical - Overview
Exhibits120: Boston Analytical - Product / Service
Exhibits121: Boston Analytical - Key news
Exhibits122: Boston Analytical - Key offerings
Exhibits123: Catalent Inc. - Overview
Exhibits124: Catalent Inc. - Business segments
Exhibits125: Catalent Inc. - Key news
Exhibits126: Catalent Inc. - Key offerings
Exhibits127: Catalent Inc. - Segment focus
Exhibits128: Charles River Laboratories International Inc. - Overview
Exhibits129: Charles River Laboratories International Inc. - Business segments
Exhibits130: Charles River Laboratories International Inc. - Key news
Exhibits131: Charles River Laboratories International Inc. - Key offerings
Exhibits132: Charles River Laboratories International Inc. - Segment focus
Exhibits133: Coriolis Pharma Research GmbH - Overview
Exhibits134: Coriolis Pharma Research GmbH - Product / Service
Exhibits135: Coriolis Pharma Research GmbH - Key offerings
Exhibits136: Element Materials Technology Group Ltd. - Overview
Exhibits137: Element Materials Technology Group Ltd. - Product / Service
Exhibits138: Element Materials Technology Group Ltd. - Key offerings
Exhibits139: Eurofins Scientific SE - Overview
Exhibits140: Eurofins Scientific SE - Business segments
Exhibits141: Eurofins Scientific SE - Key news
Exhibits142: Eurofins Scientific SE - Key offerings
Exhibits143: Eurofins Scientific SE - Segment focus
Exhibits144: ICON plc - Overview
Exhibits145: ICON plc - Product / Service
Exhibits146: ICON plc - Key offerings
Exhibits147: Intertek Group Plc - Overview
Exhibits148: Intertek Group Plc - Business segments
Exhibits149: Intertek Group Plc - Key news
Exhibits150: Intertek Group Plc - Key offerings
Exhibits151: Intertek Group Plc - Segment focus
Exhibits152: Merck KGaA - Overview
Exhibits153: Merck KGaA - Business segments
Exhibits154: Merck KGaA - Key news
Exhibits155: Merck KGaA - Key offerings
Exhibits156: Merck KGaA - Segment focus
Exhibits157: Pace Analytical Services LLC - Overview
Exhibits158: Pace Analytical Services LLC - Product / Service
Exhibits159: Pace Analytical Services LLC - Key offerings
Exhibits160: SGS SA - Overview
Exhibits161: SGS SA - Business segments
Exhibits162: SGS SA - Key offerings
Exhibits163: SGS SA - Segment focus
Exhibits164: Solvias AG - Overview
Exhibits165: Solvias AG - Product / Service
Exhibits166: Solvias AG - Key news
Exhibits167: Solvias AG - Key offerings
Exhibits168: STERIS Plc - Overview
Exhibits169: STERIS Plc - Business segments
Exhibits170: STERIS Plc - Key news
Exhibits171: STERIS Plc - Key offerings
Exhibits172: STERIS Plc - Segment focus
Exhibits173: West Pharmaceutical Services Inc. - Overview
Exhibits174: West Pharmaceutical Services Inc. - Business segments
Exhibits175: West Pharmaceutical Services Inc. - Key news
Exhibits176: West Pharmaceutical Services Inc. - Key offerings
Exhibits177: West Pharmaceutical Services Inc. - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(biopharmaceutical)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る